BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer

NCT00006086 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: BMS-188797
DRUG: carboplatin

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]